ATE517096T1 - Verfahren zur herstellung von aminopyrimidinen - Google Patents

Verfahren zur herstellung von aminopyrimidinen

Info

Publication number
ATE517096T1
ATE517096T1 AT05729737T AT05729737T ATE517096T1 AT E517096 T1 ATE517096 T1 AT E517096T1 AT 05729737 T AT05729737 T AT 05729737T AT 05729737 T AT05729737 T AT 05729737T AT E517096 T1 ATE517096 T1 AT E517096T1
Authority
AT
Austria
Prior art keywords
alkyl
compound
formula
aminopyrimidines
producing
Prior art date
Application number
AT05729737T
Other languages
English (en)
Inventor
Ulf Larsson
Kajsa Radevik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE517096T1 publication Critical patent/ATE517096T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05729737T 2004-03-31 2005-03-29 Verfahren zur herstellung von aminopyrimidinen ATE517096T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401001A SE0401001D0 (sv) 2004-03-31 2004-03-31 Chemical process
PCT/GB2005/001188 WO2005095358A2 (en) 2004-03-31 2005-03-29 Process for the preparation of aminopyrimidines

Publications (1)

Publication Number Publication Date
ATE517096T1 true ATE517096T1 (de) 2011-08-15

Family

ID=32294337

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05729737T ATE517096T1 (de) 2004-03-31 2005-03-29 Verfahren zur herstellung von aminopyrimidinen

Country Status (23)

Country Link
US (2) US7799914B2 (de)
EP (2) EP1751117B1 (de)
JP (1) JP5059599B2 (de)
KR (1) KR101164265B1 (de)
CN (2) CN101851212A (de)
AT (1) ATE517096T1 (de)
AU (1) AU2005227727B2 (de)
BR (1) BRPI0509323A (de)
CA (1) CA2560094C (de)
CY (1) CY1111847T1 (de)
DK (1) DK1751117T3 (de)
ES (1) ES2368069T3 (de)
HR (1) HRP20110658T1 (de)
IL (1) IL177998A (de)
NO (1) NO20064117L (de)
NZ (2) NZ587999A (de)
PL (1) PL1751117T3 (de)
PT (1) PT1751117E (de)
SE (1) SE0401001D0 (de)
SG (1) SG151311A1 (de)
SI (1) SI1751117T1 (de)
WO (1) WO2005095358A2 (de)
ZA (1) ZA200607708B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process
TWI385156B (zh) * 2006-02-13 2013-02-11 Lonza Ag 5-(芳基-二氮烯基)-4,6-二鹵-嘧啶之還原作用
KR101669297B1 (ko) 2008-09-09 2016-10-25 아스트라제네카 아베 [1S-[1-알파,2-알파,3-베타(1S*,2R*),5-베타]]-3-[7-[2-(3,4-디플루오로페닐)-사이클로프로필아미노]-5-(프로필티오)-3H-1,2,3-트리아졸로[4,5-d]피리미딘-3-일]-5-(2-하이드록시에톡시)사이클로펜탄-1,2-디올의 제조 방법 및 그 중간체
EP2305376A1 (de) * 2009-09-23 2011-04-06 Lonza Ltd. Prozess und Katalysator zur katalytischen Hydrierung von aromatischen und heteroaromatischen Nitroverbindungen
US9233966B2 (en) 2012-04-05 2016-01-12 Dr. Reddy's Laboratories Limited Preparation of ticagrelor
CN103130726A (zh) * 2013-02-07 2013-06-05 许学农 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法
WO2014206187A1 (zh) 2013-06-24 2014-12-31 苏州明锐医药科技有限公司 替卡格雷及其中间体的制备方法
CA2921956C (en) 2013-08-22 2021-10-19 Genentech, Inc. Process for preparing (r)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1h-pyrrolo[2,3-b]pyridine
CN103588712B (zh) * 2013-11-08 2016-06-08 南京欧信医药技术有限公司 一种嘧啶类化合物及其制备方法、和应用
CN103923020A (zh) * 2014-04-02 2014-07-16 黄河三角洲京博化工研究院有限公司 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法
CN105020602B (zh) * 2014-04-30 2017-12-08 欧普照明股份有限公司 一种led灯
CN103992277A (zh) * 2014-05-16 2014-08-20 苏州天马精细化学品股份有限公司 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法
CN105294573B (zh) * 2015-06-16 2018-07-10 厦门医学院 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法
CN116283796A (zh) * 2023-02-14 2023-06-23 上海汇伦医药股份有限公司 一种循环催化氢化硝基化合物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0579643A1 (de) * 1991-04-06 1994-01-26 FISONS plc ATP-Analogen
CZ289721B6 (cs) 1995-05-19 2002-03-13 Syngenta Participations Ag Způsob katalytické hydrogenace aromatických nitrosloučenin
AR017014A1 (es) 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013488D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Chemical compound
US6818720B2 (en) * 2001-11-08 2004-11-16 Degussa Ag Supported hydrogenating catalyst in powder form
SE0401001D0 (sv) * 2004-03-31 2004-03-31 Astrazeneca Ab Chemical process

Also Published As

Publication number Publication date
IL177998A (en) 2012-03-29
DK1751117T3 (da) 2011-10-10
KR101164265B1 (ko) 2012-07-09
JP2007530650A (ja) 2007-11-01
CA2560094A1 (en) 2005-10-13
CN1938284B (zh) 2010-08-11
KR20060133019A (ko) 2006-12-22
IL177998A0 (en) 2006-12-31
SI1751117T1 (sl) 2011-10-28
AU2005227727A1 (en) 2005-10-13
NO20064117L (no) 2006-10-30
US20100324289A1 (en) 2010-12-23
HRP20110658T1 (hr) 2011-10-31
PT1751117E (pt) 2011-09-19
EP2308853A1 (de) 2011-04-13
ES2368069T3 (es) 2011-11-14
NZ550128A (en) 2010-10-29
US20070219371A1 (en) 2007-09-20
PL1751117T3 (pl) 2011-11-30
CA2560094C (en) 2012-10-30
CN101851212A (zh) 2010-10-06
BRPI0509323A (pt) 2007-09-04
SE0401001D0 (sv) 2004-03-31
EP1751117A2 (de) 2007-02-14
CY1111847T1 (el) 2015-10-07
JP5059599B2 (ja) 2012-10-24
SG151311A1 (en) 2009-04-30
WO2005095358A2 (en) 2005-10-13
WO2005095358A3 (en) 2006-01-05
NZ587999A (en) 2012-04-27
CN1938284A (zh) 2007-03-28
ZA200607708B (en) 2008-06-25
EP1751117B1 (de) 2011-07-20
HK1103727A1 (en) 2007-12-28
US7799914B2 (en) 2010-09-21
AU2005227727B2 (en) 2009-03-26

Similar Documents

Publication Publication Date Title
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
CY1111847T1 (el) Διαδικασια για την παρασκευη αμινοπυριμιδινων
ATE556085T1 (de) Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna
ATE496928T1 (de) Bisacylphosphane und ihre verwendung als photoinitiatoren, verfahren zur herstellung von acylphosphanen
DE60316006D1 (de) Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin
ATE506356T1 (de) Verfahren zur herstellung von 3-halo-4,5-dihydro- 1h-pyrazolen
ATE442363T1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
DE60238367D1 (de) Asymmetrischer Kupferkomplex und dessen Verwendung in Cyclopropanierungsreaktion
DE50204181D1 (de) Phthalsäurediamide, ein verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE521594T1 (de) Verfahren zur herstellung von chinolin-3- carbonsäureverbindungen
ATE501120T1 (de) Verfahren zur herstellung von isoindolderivaten
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
ATE459617T1 (de) Verfahren zur herstellung von pyridinmethylsulphinylverbindungen
ATE363460T1 (de) Verfahren zur herstellung von fluorhalogenalkanen
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
ATE469141T1 (de) Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten
ATE353877T1 (de) Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern
ATE399757T1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
ATE492523T1 (de) Verfahren zur herstellung von halogensubstituiertem benzoldimethanol
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten
ATE513824T1 (de) Verfahren zur herstellung von isothiocyanato-2,2- difluorbenzo-(1,3)-dioxolen
DE602005022213D1 (de) Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus
ATE367384T1 (de) Verfahren zur herstellung von alkoxycarbonylmethoxy-cyclopentanen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1751117

Country of ref document: EP